Related references
Note: Only part of the references are listed.A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
Jiangling Peng et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2022)
A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19
Robert L. Chapman et al.
MEDICINAL CHEMISTRY RESEARCH (2022)
Neurological Manifestations in COVID-19 Infection: A Systematic Review and Meta-Analysis
Maria Epifania V. Collantes et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2021)
Encephalitic syndrome and anosmia in COVID-19: Do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases
Lydia Pouga
JOURNAL OF MEDICAL VIROLOGY (2021)
A systematic review of neurological symptoms and complications of COVID-19
Xiangliang Chen et al.
JOURNAL OF NEUROLOGY (2021)
Current Scenario and Future Prospect in the Management of COVID-19
Pobitra Borah et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of the respiratory center of the brain
Jhilik Dey et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches
Vinit Raj et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Neuroinvasion of SARS-CoV-2 in human and mouse brain
Eric Song et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
Jenny Meinhardt et al.
NATURE NEUROSCIENCE (2021)
Neurological infection with SARS-CoV-2-the story so far
Tom Solomon
NATURE REVIEWS NEUROLOGY (2021)
Cannabidiol: pharmacology and therapeutic targets
Stevie C. Britch et al.
PSYCHOPHARMACOLOGY (2021)
Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages
Seegehalli M. Anil et al.
SCIENTIFIC REPORTS (2021)
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19
Barbara Malinowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPARγ-dependent TLR4/NLRP3/Caspase-1 signaling suppression in Caco-2 cell line
Chiara Corpetti et al.
PHYTOTHERAPY RESEARCH (2021)
Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted
Pobitra Borah et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung
Gaetano Bulfamante et al.
JOURNAL OF NEUROLOGY (2021)
In Vitro Evaluation of the Activity of Terpenes and Cannabidiol against Human Coronavirus E229
Lior Chatow et al.
LIFE-BASEL (2021)
Neuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation
Ludmila A. Kasatkina et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic A Randomized Clinical Trial
Jose Alexandre S. Crippa et al.
JAMA NETWORK OPEN (2021)
Putative mechanism of neurological damage in COVID-19 infection
Cindy Bandala et al.
ACTA NEUROBIOLOGIAE EXPERIMENTALIS (2021)
Acute and Post-Acute Neurological Complications of COVID-19
Ali Al-Ramadan et al.
NEUROLOGY INTERNATIONAL (2021)
Neuroprotection Following Concussion: The Potential Role for Cannabidiol
Jyotpal Singh et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2020)
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients
Yan-Chao Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
The 2019 novel cornoavirus pneumonia with onset of oculomotor nerve palsy: a case study
Heng Wei et al.
JOURNAL OF NEUROLOGY (2020)
Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson's Disease
Rachel Kelly et al.
MOLECULES (2020)
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Luigia Cristino et al.
NATURE REVIEWS NEUROLOGY (2020)
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Hao Xu et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2020)
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms
Abdul Mannan Baig et al.
ACS CHEMICAL NEUROSCIENCE (2020)
SARS-CoV-2 Detected in Cerebrospinal Fluid by PCR in a Case of COVID-19 Encephalitis
Y. Hanna Huang et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020
Lisa Duong et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Yung-Fang Tu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cannabis in the Time of Coronavirus Disease 2019: The Yin and Yang of the Endocannabinoid System in Immunocompetence
Michelle Sexton
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2020)
Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
Alberto Paniz-Mondolfi et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
Ling Mao et al.
JAMA NEUROLOGY (2020)
Interferon-α2b Treatment for COVID-19
Qiong Zhou et al.
FRONTIERS IN IMMUNOLOGY (2020)
The proximal origin of SARS-CoV-2
Kristian G. Andersen et al.
NATURE MEDICINE (2020)
The neurological manifestations of COVID-19: a review article
Hamid Reza Niazkar et al.
NEUROLOGICAL SCIENCES (2020)
Effects of Chronic Cannabidiol Treatment in the Rat Chronic Unpredictable Mild Stress Model of Depression
Zsolt Gall et al.
BIOMOLECULES (2020)
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
Ross W. Paterson et al.
BRAIN (2020)
The potential of cannabidiol in theCOVID-19pandemic
Giuseppe Esposito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Glial cells in Parkinson′s disease: protective or deleterious?
Ana V. Domingues et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Protective role of neuronal and lymphoid cannabinoid CB2 receptors in neuropathic pain
David Cabanero et al.
ELIFE (2020)
Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study
Yanan Li et al.
STROKE AND VASCULAR NEUROLOGY (2020)
Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms
Bernhard Neumann et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Outbreak of COVID-19: An emerging global pandemic threat
Minhua Peng
BIOMEDICINE & PHARMACOTHERAPY (2020)
First ultrastructural autoptic findings of SARS-Cov-2 in olfactory pathways and brainstem
Gaetano Bulfamante et al.
MINERVA ANESTESIOLOGICA (2020)
COVID-19 Infection and Neurological Complications: Present Findings and Future Predictions
Ettore Beghi et al.
NEUROEPIDEMIOLOGY (2020)
Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System
Maria Lima et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2020)
Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome?
Simon B. Gane et al.
RHINOLOGY (2020)
Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats
Olga Sadowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease
Aleksandra Kicman et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome
Evila Lopes Salles et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
The Essential Medicinal Chemistry of Cannabidiol (CBD)
Kathryn M. Nelson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
In search of preventative strategies: novel high-CBD cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues
Bo Wang et al.
Aging-US (2020)
Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson's Disease
Felipe Patricio et al.
FRONTIERS IN PHARMACOLOGY (2020)
Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives
Sabna Kotta et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA
Hesam Khodadadi et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020
Karima Benameur et al.
EMERGING INFECTIOUS DISEASES (2020)
Debunking Cannabidiol as a Treatment for COVID-19: Time for the FDA to Adopt a Focused Deterrence Model?
Chelsea L. Shover et al.
CUREUS (2020)
Cannabidiol Affects the Bezold-Jarisch Reflex via TRPV1 and 5-HT3 Receptors and Has Peripheral Sympathomimetic Effects in Spontaneously Hypertensive and Normotensive Rats
Rafal Kossakowski et al.
FRONTIERS IN PHARMACOLOGY (2019)
Macrophage PPAR-γ suppresses long-term lung fibrotic sequelae following acute influenza infection
Su Huang et al.
PLOS ONE (2019)
Cannabidiol differentially regulates basal and LPS-induced inflammatory responses in macrophages, lung epithelial cells, and fibroblasts
Thivanka Muthumalage et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
Crystal Structure of the Human Cannabinoid Receptor CB2
Xiaoting Li et al.
CELL (2019)
Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models
Pabitra Hriday Patra et al.
EPILEPSIA (2019)
Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma
Francieli Vuolo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Cannabidiol reduces seizures following CNS infection with Theiler's murine encephalomyelitis virus
Dipan C. Patel et al.
EPILEPSIA OPEN (2019)
Cannabinoid Receptor Type 1 Agonist ACEA Protects Neurons from Death and Attenuates Endoplasmic Reticulum Stress-Related Apoptotic Pathway Signaling
Talita A. Vrechi et al.
NEUROTOXICITY RESEARCH (2018)
Endocannabinoid system, stress and HPA axis
Vincenzo Micale et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Within the Brain: The Renin Angiotensin System
LaDonya Jackson et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology
Anne-Caroline Schmoele et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43
Mathieu Dube et al.
JOURNAL OF VIROLOGY (2018)
Cannabinoid type 2 receptors mediate a cell type-specific self-inhibition in cortical neurons
Alexander Stumpf et al.
NEUROPHARMACOLOGY (2018)
The Role of Cannabinoid Receptor 1 in the Immunopathology of Respiratory Syncytial Virus
Alireza Tahamtan et al.
VIRAL IMMUNOLOGY (2018)
Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response
Sara Bachiller et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Neurologic Alterations Due to Respiratory Virus Infections
Karen Bohmwald et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Neurotoxic reactive astrocytes are induced by activated microglia
Shane A. Liddelow et al.
NATURE (2017)
Crystal structures of agonist-bound human cannabinoid receptor CB1
Tian Hua et al.
NATURE (2017)
Immunoregulatory Role of Cannabinoids during Infectious Disease
Rosalia Hernandez-Cervantes et al.
NEUROIMMUNOMODULATION (2017)
Allodynia Lowering Induced by Cannabinoids and Endocannabinoids (ALICE)
Livio Luongo et al.
PHARMACOLOGICAL RESEARCH (2017)
Apoptosis and Necroptosis as Host Defense Strategies to Prevent Viral Infection
Megan H. Orzalli et al.
TRENDS IN CELL BIOLOGY (2017)
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
Marjolein Soethoudt et al.
NATURE COMMUNICATIONS (2017)
Serotonin Signaling through Prefrontal Cortex 5-HT1A Receptors during Adolescence Can Determine Baseline Mood-Related Behaviors
Alvaro L. Garcia-Garcia et al.
CELL REPORTS (2017)
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
Tommaso Cassano et al.
FRONTIERS IN NEUROSCIENCE (2017)
Potential of Cannabidiol for the Treatment of Viral Hepatitis
Henry I. C. Lowe et al.
PHARMACOGNOSY RESEARCH (2017)
Activation of PPARγ inhibits pro-inflammatory cytokines production by upregulation of miR-1.24 in vitro and in vivo
Dan Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Effects of cannabinoids and their receptors on viral infections
Alireza Tahamtan et al.
JOURNAL OF MEDICAL VIROLOGY (2016)
An update on PPAR activation by cannabinoids
Saoirse Elizabeth O'Sullivan
BRITISH JOURNAL OF PHARMACOLOGY (2016)
The CB2 receptor and its role as a regulator of inflammation
Caroline Turcotte et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine
Ester Aso et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth
Omran Abu Aboud et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
A. Vanessa Stempel et al.
NEURON (2016)
Microglia activation states and cannabinoid system: Therapeutic implications
M. Mecha et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Astrocytes: Key Regulators of Neuroinflammation
Emanuela Colombo et al.
TRENDS IN IMMUNOLOGY (2016)
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson's disease
Young C. Chung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling
Lei Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission
Jimok Kim et al.
JOURNAL OF PHYSIOLOGY-LONDON (2015)
Hypothalamic POMC neurons promote cannabinoid-induced feeding
Marco Koch et al.
NATURE (2015)
Endocannabinoid signalling and the deteriorating brain
Vincenzo Di Marzo et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
Javier Fernandez-Ruiz et al.
NEUROTHERAPEUTICS (2015)
Endocannabinoid signaling at the periphery: 50 years after THC
Mauro Maccarrone et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer's Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline
Claudia Altamura et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions
Livio Luongo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2014)
Validating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity
Yannick Marchalant et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2014)
Functions of the CB1 and CB2 Receptors in Neuroprotection at the Level of the Blood-Brain Barrier
Esmee Vendel et al.
NEUROMOLECULAR MEDICINE (2014)
Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement
Caterina Scuderi et al.
PHYTOTHERAPY RESEARCH (2014)
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1aΔE9 mice
David Cheng et al.
PSYCHOPHARMACOLOGY (2014)
The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders
Cristoforo Silvestri et al.
CELL METABOLISM (2013)
Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington's disease and mouse models
Eric A. Horne et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation
Slava Rom et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer's Disease
Jeremy Koppel et al.
MOLECULAR MEDICINE (2013)
PPARγ signaling and metabolism: the good, the bad and the future
Maryam Ahmadian et al.
NATURE MEDICINE (2013)
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
M. Mecha et al.
NEUROBIOLOGY OF DISEASE (2013)
Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: Role of 5HT1A and CB2 receptors
M. Ruth Pazos et al.
NEUROPHARMACOLOGY (2013)
The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig
A. Dudasova et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2013)
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice
Ester Aso et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling
Javier Palazuelos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Systemic Analysis of PPARγ in Mouse Macrophage Populations Reveals Marked Diversity in Expression with Critical Roles in Resolution of Inflammation and Airway Immunity
Emmanuel L. Gautier et al.
JOURNAL OF IMMUNOLOGY (2012)
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice
Ana Maria Martin-Moreno et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntington's Disease
Jill Bouchard et al.
JOURNAL OF NEUROSCIENCE (2012)
Mitochondrial CB1 receptors regulate neuronal energy metabolism
Giovanni Benard et al.
NATURE NEUROSCIENCE (2012)
An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer's disease
Kwang-Mook Jung et al.
NEUROBIOLOGY OF AGING (2012)
Endocannabinoid Signaling and Synaptic Function
Pablo E. Castillo et al.
NEURON (2012)
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease
Cristina Blazquez et al.
BRAIN (2011)
Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease
C. Garcia et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Disease-Related Changes in TRPV1 Expression and Its Implications for Drug Development
Louis S. Premkumar et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection
Peer W. F. Karmaus et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Worsening of Huntington disease phenotype in CB1 receptor knockout mice
Stephane Mievis et al.
NEUROBIOLOGY OF DISEASE (2011)
The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases
Sandeep Tyagi et al.
JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH (2011)
Receptors and Channels Targeted by Synthetic Cannabinoid Receptor Agonists and Antagonists
R. G. Pertwee
CURRENT MEDICINAL CHEMISTRY (2010)
The endocannabinoid system as a target for the treatment of neuronal damage
Javier Fernandez-Ruiz et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Cannabinoid and Cannabinoid-Like Receptors in Microglia, Astrocytes, and Astrocytomas
Nephi Stella
GLIA (2010)
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
Sadiye Amcaoglu Rieder et al.
IMMUNOBIOLOGY (2010)
Cannabinoids and the immune system: An overview
Radu Tanasescu et al.
IMMUNOBIOLOGY (2010)
Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease
S. E. O'Sullivan et al.
IMMUNOBIOLOGY (2010)
Dynamic Changes of Anandamide in the Cerebrospinal Fluid of Parkinson's Disease Patients
Valerio Pisani et al.
MOVEMENT DISORDERS (2010)
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB2 and adenosine receptors
A. Castillo et al.
NEUROBIOLOGY OF DISEASE (2010)
Oleamide suppresses lipopolysaccharide-induced expression of iNOS and COX-2 through inhibition of NF-κB activation in BV2 murine microglial cells
Young Taek Oh et al.
NEUROSCIENCE LETTERS (2010)
Cannabinoids and Viral Infections
Carol Shoshkes Reiss
PHARMACEUTICALS (2010)
Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands
Q. -R. Liu et al.
GENES BRAIN AND BEHAVIOR (2009)
Peroxisome Proliferator-Activated Receptor-γ Agonists Promote Differentiation and Antioxidant Defenses of Oligodendrocyte Progenitor Cells
Antonietta Bernardo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Does neuroinflammation fan the flame in neurodegenerative diseases?
Tamy C. Frank-Cannon et al.
MOLECULAR NEURODEGENERATION (2009)
The Endocannabinoid 2-Arachidonoylglycerol Is Responsible for the Slow Self-Inhibition in Neocortical Interneurons
Silvia Marinelli et al.
JOURNAL OF NEUROSCIENCE (2008)
Targeting the endocannabinoid system: to enhance or reduce?
Vincenzo Di Marzo
NATURE REVIEWS DRUG DISCOVERY (2008)
Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Δ9-tetrahydrocannabinol
John P. Buchweitz et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol
Jacqueline L. Blankman et al.
CHEMISTRY & BIOLOGY (2007)
Endocannabinoids and neurodegenerative diseases
Vincenzo Micale et al.
PHARMACOLOGICAL RESEARCH (2007)
Statins activate peroxisome proliferator-activated receptor γ through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages
Miyuki Yano et al.
CIRCULATION RESEARCH (2007)
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease:: Importance of antioxidant and cannabinoid receptor-independent properties
Moises Garcia-Arencibia et al.
BRAIN RESEARCH (2007)
Endocannabinoids and β-amyloid-induced neurotoxicity in vivo:: effect of pharmacological elevation of endocannabinoid levels
M. van der Stelt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice
Lynsey G. Bilsland et al.
FASEB JOURNAL (2006)
Involvement of the endocannabinoid system in drug addiction
R Maldonado et al.
TRENDS IN NEUROSCIENCES (2006)
Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity
SH Kim et al.
MOLECULAR PHARMACOLOGY (2006)
Coronavirus infection of the central nervous system: host-virus stand-off
CC Bergmann et al.
NATURE REVIEWS MICROBIOLOGY (2006)
Cannabinoid signalling
DG Demuth et al.
LIFE SCIENCES (2006)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Agonistic properties of cannabidiol at 5-HT1a receptors
EB Russo et al.
NEUROCHEMICAL RESEARCH (2005)
A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTPlesioned non-human primate models of Parkinson's disease
M van der Stelt et al.
FASEB JOURNAL (2005)
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients
A Pisani et al.
ANNALS OF NEUROLOGY (2005)
A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis
C Benito et al.
JOURNAL OF NEUROSCIENCE (2005)
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
Jared Ehrhart et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain:: An immunohistochemical study
E Núñez et al.
SYNAPSE (2004)
Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation
B Costa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Vacuolating encephalitis in mice infected by human coronavirus OC43
H Jacomy et al.
VIROLOGY (2003)
Amnesia induced by β-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade
C Mazzola et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors
A Franklin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Nonpsychotropic cannabinoid receptors regulate microglial cell migration
L Walter et al.
JOURNAL OF NEUROSCIENCE (2003)
CB1 cannabinoid receptor signalling in Parkinson's disease
JM Brotchie
CURRENT OPINION IN PHARMACOLOGY (2003)
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-β peptide
NGN Milton
NEUROSCIENCE LETTERS (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2
KR Kozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The pattern of neurodegeneration in Huntington's disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease
M Glass et al.
NEUROSCIENCE (2000)
Share Paper
